EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports Successful Conclusion of Patent Examination Procedure for Patent Application Entitled, 'Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis'
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Reports Successful Conclusion of Patent Examination Procedure for Patent Application Entitled, 'Vasoactive Intestinal Peptide
Michael Miller Raghuram Ram Selvaraju Jack Weinstein Advita Lifescience Gmb National Institutes Of Health Pharma Research
Source: finanznachrichten.de